Binz, Camilla
Schreiber-Katz, Olivia
Kumpe, Mareike
Ranxha, Gresa
Siegler, Hannah
Wieselmann, Gary
Petri, Susanne
Osmanovic, Alma
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 26 June 2020
Revised: 10 September 2020
Accepted: 12 September 2020
First Online: 7 October 2020
Compliance with ethical standards
:
: Camilla Binz reports no disclosures. Olivia Schreiber-Katz has received honoraria as a speaker/consultant and/or funding for travel expenses from the German Neuromuscular Society “Deutsche Gesellschaft fuer Muskelkranke (DGM e.V.), Novartis, Biogen GmbH, Biermann Verlag GmbH and the Jain Foundation. She has received research support from the German Neuromuscular Society “Deutsche Gesellschaft fuer Muskelkranke (DGM e.V.), 2019–2020. Mareike Kumpe and Gresa Ranxha received travel cost compensation from Biogen GmbH. Hannah Siegler and Gary Wieselmann report no disclosures. Susanne Petri has received speaker/ consultant honoraria and funding for travel expenses from Biogen, Cytokinetics, Inc., Desitin Pharma, Novartis, Roche, Teva. Alma Osmanovic has received honoraria as a speaker/consultant from the German Neuromuscular Society “Deutsche Gesellschaft fuer Muskelkranke (DGM e.V.) and Biogen GmbH.
: The study has been approved by the local ethics review board of Hannover Medical School (no. 6269) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All patients gave their written informed consent before entering the study.
: All study participants gave their written informed consent to the publication of anonymized cohort data.